BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$231M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$145M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$63M |
| 4 |
Pinterest
PINS
|
+$53.4M |
| 5 |
Prologis
PLD
|
+$50.8M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$4.18B |
| 2 |
Apple
AAPL
|
+$1.93B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.78B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Microsoft
MSFT
|
+$1.2B |
Sector Composition
| 1 | Technology | 16.91% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Financials | 12.2% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
West Bancorporation
WTBA
$349M
| $75.6K | ﹤0.01% |
3,915
-45
| -1% | -$869 |
|
|
ISEE
2577
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $75.3K | ﹤0.01% |
10,892
-8,205
| -43% | -$56.7K |
|
|
BPMP
2578
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $75.2K | ﹤0.01% |
7,097
-1,272
| -15% | -$13.5K |
|
|
BFS
2579
Saul Centers
BFS
$785M
| $75.1K | ﹤0.01% |
2,372
-673
| -22% | -$21.3K |
|
2580
Entravision Communication
EVC
$222M
| $75.1K | ﹤0.01% |
27,302
+14,242
| +109% | +$39.2K |
|
2581
Merchants Bancorp
MBIN
$1.49B
| $75K | ﹤0.01% |
4,073
+749
| +23% | +$13.8K |
|
2582
Red Robin
RRGB
$120M
| $75K | ﹤0.01% |
3,899
+361
| +10% | +$6.94K |
|
|
KDMN
2583
DELISTED
Kadmon Holdings, Inc.
KDMN
| $74.8K | ﹤0.01% |
18,033
-22,829
| -56% | -$94.7K |
|
|
FRGI
2584
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $74.6K | ﹤0.01% |
6,547
+1,973
| +43% | +$22.5K |
|
|
BRG
2585
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $74.6K | ﹤0.01% |
5,889
-250
| -4% | -$3.17K |
|
2586
Berry Corp
BRY
$258M
| $74.6K | ﹤0.01% |
20,268
+4,153
| +26% | +$15.3K |
|
2587
Artesian Resources
ARTNA
$342M
| $74.3K | ﹤0.01% |
2,005
+86
| +4% | +$3.19K |
|
2588
Metropolitan Bank Holding Corp
MCB
$815M
| $74.3K | ﹤0.01% |
2,048
+262
| +15% | +$9.5K |
|
|
CBAY
2589
DELISTED
Cymabay Therapeutics
CBAY
| $73.9K | ﹤0.01% |
12,877
-7,989
| -38% | -$45.9K |
|
|
CALA
2590
DELISTED
Calithera Biosciences, Inc
CALA
| $73.8K | ﹤0.01% |
751
-146
| -16% | -$14.3K |
|
2591
Gossamer Bio
GOSS
$782M
| $73.7K | ﹤0.01% |
7,618
-5,701
| -43% | -$55.1K |
|
2592
Spero Therapeutics
SPRO
$107M
| $73.6K | ﹤0.01% |
3,794
+473
| +14% | +$9.17K |
|
2593
Village Super Market
VLGEA
$579M
| $73.5K | ﹤0.01% |
3,332
+1,363
| +69% | +$30.1K |
|
2594
CRA International
CRAI
$1.31B
| $73.3K | ﹤0.01% |
1,440
-319
| -18% | -$16.2K |
|
2595
FRP Holdings
FRPH
$484M
| $73.1K | ﹤0.01% |
3,210
+150
| +5% | +$3.42K |
|
2596
Prothena Corp
PRTA
$447M
| $73K | ﹤0.01% |
6,082
-3,940
| -39% | -$47.3K |
|
|
BCEL
2597
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $72.9K | ﹤0.01% |
4,516
-2,450
| -35% | -$39.6K |
|
2598
MEI Pharma
MEIP
| $72.9K | ﹤0.01% |
1,381
+40
| +3% | +$2.11K |
|
2599
Q32 Bio
QTTB
$23.2M
| $72.6K | ﹤0.01% |
357
-79
| -18% | -$16.1K |
|
|
CNCE
2600
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $72.5K | ﹤0.01% |
5,738
-1,002
| -15% | -$12.7K |
|